Scientific Programme

The 32nd Annual Meeting Scientific Committee established an inspiring programme* on the topic "Changes in MS in the past 25 years: Impact on Treatment"

* Changes to the programme may apply.

Hour
Location
Title Location
11:30 - 12:30
Satellite Symposium I
12:30 - 13:30
Light Lunch & Poster Viewing Session I
13:30 - 13:35
Opening
Prof. Giancarlo Comi
13:35 - 13:45
Introduction
Prof. Giancarlo Comi
13:45 - 14:15
XXXII ECF Lecture
Prof. Dr Ludwig Kappos
14:15 - 15:45
Session I - Mechanistic aspects
Prof. Dr Krzysztof Selmaj
14:15 - 14:35 Lifestyle/Environmental Factors and their Interactions with MS HLA Risk Genes
Prof. Dr Tomas Olsson
 
14:35 - 14:55 From T cells to B cells
Prof. Dr Amit Bar-Or
 
14:55 - 15:15 Mechanisms of acute and chronic tissue injury
Prof. Dr Manuel Alexander Friese
 
15:15 - 15:35 Pathophysiology and clinical courses
Prof. Dr Hans Lassmann
 
15:35 - 15:45 Q&A
 
15:45 - 17:15
Session II - Early treatment
15:45 - 16:05 Why early treatment
Prof. Dr Mark S. Freedman
 
16:05 - 16:25 Therapeutic Options for Early MS
Prof. Dr Christine Lebrun-Frenay
 
16:25 - 16:45 The growing role of RWE
Prof. Dr Maria Trojano
 
16:45 - 17:05 Diagnostic criteria
Prof. Dr Xavier Montalban
 
17:05 - 17:15 Q&A
 
17:15 - 18:15
Coffee Break & Poster Viewing Session II
18:15 - 19:15
Satellite Symposium II
19:15 - 20:00
Scientific Networking Cocktail
Hour
Location
Title Location
08:30 - 10:00
Session III - High efficacy DMTs
Prof. Dr Oscar Fernández
08:30 - 08:50 Rationale
Prof. Dr Heinz Wiendl
 
08:50 - 09:10 Evidences from clinical trials
Prof. Dr Hans-Peter Hartung
 
09:10 - 09:30 Induction Strategy: Lessons from 25 Years of Experience
Prof. Dr Gilles Edan
 
09:30 - 09:50 HSCT
Prof. Dr Paolo Muraro
 
09:50 - 10:00 Q&A
 
10:00 - 10:30
Coffee Break & Poster Viewing Session III
10:30 - 12:00
Session IV - Progressive MS
Prof. Dr Bernhard Hemmer
10:30 - 10:50 The evolving perception of Progressive MS
Prof. Dr Alan Thompson
 
10:50 - 11:10 Treatment of PMS
Prof. Dr Fred Lublin
 
11:10 - 11:30 Progressive MS in observational data: Definition and treatment
Prof. Tomas Kalincik
 
11:30 - 11:50 Biomarkers in progressive MS
Prof. Dr Daniel Ontaneda
 
11:50 - 12:00 Q&A
 
12:00 - 13:00
Satellite Symposium III
13:00 - 14:00
Light Lunch & Poster Viewing Session IV
14:00 - 15:30
Session V - Age and Pregnancy
Prof. Maria Pia Amato
14:00 - 14:20 Pediatric MS
Prof. Dr Tanuja Chitnis
 
14:20 - 14:40 Late onset MS
Prof. Dr Celia Oreja-Guevara
 
14:40 - 15:00 Treatment discontinuation
Dr Liliana Patrucco
 
15:00 - 15:20 Pregnancy and breastfeeding
Prof. Dr Kerstin Hellwig
 
15:20 - 15:30 Q&A
 
15:30 - 17:00
Session VI - At the border of MS
Prof. Fu-Dong Shi
15:30 - 15:50 Historical perspective
Prof. Dr Jacqueline Palace
 
15:50 - 16:10 NMOSD
Prof. Dr Kazuo Fujihara
 
16:10 - 16:30 MOGAD
Dr Elisabeth Maillart
 
16:30 - 16:50 Ms PLUS
Prof. Dr Friedemann Paul
 
16:50 - 17:00 Q&A
 
17:00 - 17:20
Coffee Break
17:20 - 17:30
Announcement Young Investigator Award Winners
17:30 - 18:30
Satellite Symposium IV
18:30 - 19:00
ACTRIMS Lecture - Redefining MS: Clinical and biologic manifestations of preclinical disease
Dr Erin Longbrake
Hour
Location
Title Location
8:30 - 10:00
Session VII: Treatments in 10 years
8:30 - 8:50 Disease modifying treatments
Prof. Dr Marco Salvetti
 
8:50 - 9:10 CAR-T
Prof. Dr Ralf Gold
 
9:10 - 9:30 Cellular therapies
Prof. Dr Stefano Pluchino
 
9:30 - 9:50 Anti viral vaccination
Prof. Dr Gavin Giovannoni
 
9:50 - 10:00 Q&A
 
10:00 - 10:30
Coffee break
10:30 - 11:00
Young Investigator Awards
11:00 - 12:30
Session VIII: Moving the patient to the centre
Prof. Dr Bernard M.J. Uitdehaag
11:00 - 11:20 Historical view
Prof. Dr Paola Zaratin
 
11:20 - 11:40 Patients Reported Outcomes
Prof. Dr Patrick Vermersch
 
11:40 - 12:00 Digital medicine, the role of passive and active recording
Prof. Dr Letizia Leocani
 
12:00 - 12:20 The optimization of MS Care
Prof. Dr Per Soelberg Sørensen
 
12:20 - 12:30 Q&A
 
12:30 - 13:00
Concluding Remarks
Prof. Giancarlo Comi
13:00 - 14:00
Light Lunch